Cour Pharmaceuticals Development IPO

COUR Pharmaceuticals aims to advance novel therapies that reprogram the immune system for antigen-specific tolerance, focusing on the root of immune-mediated diseases. Their cutting-edge nanoparticle platform diverges from traditional symptom-suppressing treatments, offering a more targeted approach. Collaborating with Takeda on a leading celiac disease therapy, COUR has achieved the first instance of antigen-specific immune tolerance in autoimmune diseases. This breakthrough underscores the potential of their platform to address a wide array of immune and inflammatory conditions.

Register for Details

For more details on financing and valuation for Cour Pharmaceuticals Development, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Cour Pharmaceuticals Development

Forge green plus iconForge green minus icon

What is Cour Pharmaceuticals Development's IPO price?

The IPO price for Cour Pharmaceuticals Development will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Cour Pharmaceuticals Development?

Cour Pharmaceuticals Development is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Cour Pharmaceuticals Development shares pre-IPO?

If you own Cour Pharmaceuticals Development pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Cour Pharmaceuticals Development a publicly traded company?

Cour Pharmaceuticals Development is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Cour Pharmaceuticals Development founded?

Cour Pharmaceuticals Development was founded in 2012.

Who are Cour Pharmaceuticals Development's major investors?

Bristol Myers Squibb
T1D Fund
Chimera Capital
Lumira Ventures
Alpha Wave Global
Pfizer Ventures
Angelini Ventures
Roche Venture Fund
Updated on: Jun 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.